Next Science Ltd (AU:NXS) has released an update.
Next Science Ltd has reported a solid second quarter in FY24 with product sales reaching US$5.8 million, marking a 5% increase over the previous corresponding period and a 6% rise from the first quarter. The company’s strategic sales restructuring and cost optimization efforts have resulted in a significant reduction in net operating cash outflows. With a strong gross margin of 80% and reaffirmation of its FY24 revenue guidance of US$36-40 million, Next Science remains optimistic about achieving EBITDA and cash flow positivity in the second half of the fiscal year.
For further insights into AU:NXS stock, check out TipRanks’ Stock Analysis page.
